ANTIPHOSPHOLIPID SYNDROME
Clinical trials for ANTIPHOSPHOLIPID SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ANTIPHOSPHOLIPID SYNDROME trials appear
Sign up with your email to follow new studies for ANTIPHOSPHOLIPID SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Stem cell super soldiers take on autoimmune diseases
Disease control Not yet recruitingThis early-phase study tests a new treatment called BCT301 for people with severe autoimmune diseases like lupus and scleroderma that haven't responded to standard therapies. BCT301 uses immune cells made from stem cells to target and attack faulty immune cells. The main goal is …
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: EARLY_PHASE1 • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated May 17, 2026 03:08 UTC
-
Engineered immune cells take on lupus and more
Disease control Not yet recruitingThis early study tests a new treatment called CD19 UCAR-T cell therapy for people with autoimmune diseases like lupus, vasculitis, and Sjögren's syndrome. The therapy uses a patient's own immune cells, modified to target and calm the overactive immune system. The main goals are t…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 11, 2026 20:48 UTC
-
Scientists to investigate troublemaker cells in autoimmune diseases
Knowledge-focused Not yet recruitingThis study aims to better understand certain immune cells (B cells) that mistakenly attack the body in autoimmune diseases like lupus and scleroderma. Researchers will analyze blood samples from 200 adults with these conditions or with immune deficiencies. The goal is to identify…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 17, 2026 03:11 UTC
-
Finger-Prick vs. arm draw: study seeks to solve blood test mystery in clotting disorder
Knowledge-focused Not yet recruitingThis study looks at why finger-stick blood tests (capillary) sometimes give different results than standard arm blood draws (venous) for people with antiphospholipid syndrome who take blood thinners. Researchers will compare two finger-stick devices to the usual lab test in 150 a…
Matched conditions: ANTIPHOSPHOLIPID SYNDROME
Phase: NA • Sponsor: Central Hospital, Nancy, France • Aim: Knowledge-focused
Last updated May 17, 2026 03:00 UTC